Drugs and the liver.
D001663:Bilirubin / Q000378:metabolism; D003480:Cushing Syndrome / Q000188:drug therapy; D003634:DDT / Q000627:therapeutic use; D004790:Enzyme Induction; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000517:prevention & control; D008099:Liver / Q000187:drug effects*; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use; D010672:Phenytoin / Q000378:metabolism; D011166:Porphyrins / Q000378:metabolism; D011247:Pregnancy; D014166:Transferases / Q000032:analysis; D014859:Warfarin / Q000378:metabolism
D011166:Porphyrins; D000431:Ethanol; D014859:Warfarin; D010672:Phenytoin; D003634:DDT; D014166:Transferases; D001663:Bilirubin; D010634:Phenobarbital